Ocular Surface Disease Review II
With Ocular Surface Disease (OSD) prevalence on the rise, it has never been more important for Eye Care practitioners to understand the role of expert diagnosis and management of the disease. The 2nd International OSD review panel discussion focuses on the clinical impact and progress of the DEWS II report published in 2017. This course is a follow on from the original discussion held in 2018 just after the report was published.
The expert panel discuss and debate the new definition and classification of Dry Eye disease, the diagnostic and management protocols contained within the report and also deliver their clinical pearls for eye care practitioners. Those taking this course will benefit from the opinions and expertise of experts in the area of OSD from the US, Ireland and the UK. They will gain an evidence-based, solid understanding what drives the disease and how best to diagnose and manage for the best patient outcome and ultimately to improve the services they provide in clinic.
The panel discussion was kindly supported by Scope and the video was recorded at AAO San Francisco in October 2019.
PRIVACY NOTICE: By completing this free CET course you agree that we will pass your name and email address to Scope who may send you further information on their products and services.
CET Points: 1
CETpoints.com credits: Free
Expiry Date: 31/12/2021
Also accepted by
Blepharitis and MGD
Cross discipline perspectives on diagnosis and management for the best patient outcomes
In this round table discussion, five expert panelists discuss the diagnosis and management of blepharitis and MGD.
TFOS DEWS II: Expert Insights for Adopting Best Practice in Dry Eye Disease. Definition and Classification
Dry Eye Diagnosis and Treatment
Dry eye disease (DED) affects hundreds of millions of people throughout the world and is one of the most frequent causes of patient visits to eye care practitioners. Exacerbated by modern lifestyles, symptoms of DED vary widely from mild dryness to severe pain and blurred vision. A better understanding of this multifactorial disease has led to new and better treatments, many of which are in the realm of optometric and contact lens practice.